Extended Data Fig. 1: Overview of the C-CAT cohort.
From: Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors
a, Flow chart of patient selection (left) and corresponding subsets for overall (center; Figs. 1–3 and Extended Data Figs. 1–4) and individual biomarker analyses (right; Figs. 4 and 5, Table 1 and Extended Data Figs. 5–9). b, Distribution of tumor types among 54,185 patients in the C-CAT cohort. The inner and outer circles indicate primary organs/tissues and tumor types, respectively. Tumor types with ≥100 patients per primary organ/tissue and available subclassification details are visualized. More details are shown in Supplementary Table 1. c, Distribution of the number of mutations (log-transformed; top), copy number alterations (middle) and rearrangements (bottom) per patient in each tumor type. Black bars indicate the median.
